Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17101779)

  • 1. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.
    Burgermeister E; Chuderland D; Hanoch T; Meyer M; Liscovitch M; Seger R
    Mol Cell Biol; 2007 Feb; 27(3):803-17. PubMed ID: 17101779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma.
    Burgermeister E; Seger R
    Cell Cycle; 2007 Jul; 6(13):1539-48. PubMed ID: 17611413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1.
    Yao Z; Flash I; Raviv Z; Yung Y; Asscher Y; Pleban S; Seger R
    Oncogene; 2001 Nov; 20(52):7588-96. PubMed ID: 11753637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein-kinase-II-dependent phosphorylation of PPARgamma provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol.
    von Knethen A; Tzieply N; Jennewein C; Brüne B
    J Cell Sci; 2010 Jan; 123(Pt 2):192-201. PubMed ID: 20026644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export.
    Khateeb J; Kiyan Y; Aviram M; Tkachuk S; Dumler I; Fuhrman B
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):449-58. PubMed ID: 22155455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skp2 regulates subcellular localization of PPARγ by MEK signaling pathways in human breast cancer.
    Cheng H; Meng J; Wang G; Meng Y; Li Y; Wei D; Fu C; Deng K; Shen A; Wang H; Dai S
    Int J Mol Sci; 2013 Aug; 14(8):16554-69. PubMed ID: 23939428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation.
    Raviv Z; Kalie E; Seger R
    J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.
    Duhamel S; Hébert J; Gaboury L; Bouchard A; Simon R; Sauter G; Basik M; Meloche S
    Cancer Res; 2012 Feb; 72(3):626-35. PubMed ID: 22298595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1).
    Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN
    Int J Neuropsychopharmacol; 2009 Nov; 12(10):1337-54. PubMed ID: 19835659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis.
    Kaplan JM; Hake PW; Denenberg A; Nowell M; Piraino G; Zingarelli B
    Mol Med; 2010; 16(11-12):491-7. PubMed ID: 20809049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+/K+/Cl- cotransporter activates MAP-kinase cascade downstream to protein kinase C, and upstream to MEK.
    Panet R; Eliash M; Atlan H
    J Cell Physiol; 2006 Mar; 206(3):578-85. PubMed ID: 16222701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.
    Banks AS; McAllister FE; Camporez JP; Zushin PJ; Jurczak MJ; Laznik-Bogoslavski D; Shulman GI; Gygi SP; Spiegelman BM
    Nature; 2015 Jan; 517(7534):391-5. PubMed ID: 25409143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
    Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
    Proc Natl Acad Sci U S A; 2008 May; 105(19):6870-5. PubMed ID: 18463290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI.
    Wood P; Mulay V; Darabi M; Chan KC; Heeren J; Pol A; Lambert G; Rye KA; Enrich C; Grewal T
    J Biol Chem; 2011 Jul; 286(26):23077-92. PubMed ID: 21525007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.
    d'Abramo C; Ricciarelli R; Pronzato MA; Davies P
    J Neurochem; 2006 Aug; 98(4):1068-77. PubMed ID: 16787414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
    Roy M; Li Z; Sacks DB
    Mol Cell Biol; 2005 Sep; 25(18):7940-52. PubMed ID: 16135787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.